Who are the top shareholders of the Aurobindo Pharma?

Jul 17 2025 12:25 AM IST
share
Share Via
The top shareholders of Aurobindo Pharma include promoters holding 33.5%, mutual funds with 18.21%, and foreign institutional investors at 15.33%. HDFC Mutual Fund is the largest public shareholder, owning 4.33%.
The top shareholders of Aurobindo Pharma include a mix of promoters, mutual funds, and foreign institutional investors. The majority shareholders are the promoters, with Rpr Sons Advisors Private Limited and Mrs. P. Suneela Rani holding the largest stake at 33.5%.

In terms of institutional holdings, mutual funds hold 18.21% of the shares through 35 different schemes, while foreign institutional investors (FIIs) account for 15.33% of the holdings. The highest public shareholder is HDFC Mutual Fund, specifically through the HDFC S&P BSE 500 ETF, which holds 4.33%. Additionally, individual investors collectively own 5.47% of the company.

Overall, the ownership structure reflects a strong presence of both promoter and institutional investors.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News